64 related articles for article (PubMed ID: 20349857)
1. Short-term effect of topical brimonidine tartrate on intrastromal corneal pressure in rabbits.
Bolívar G; Teus MA; Hernández-Verdejo JL
J Refract Surg; 2010 Jul; 26(7):533-5. PubMed ID: 20349857
[TBL] [Abstract][Full Text] [Related]
2. Effect of prophylactic topical brimonidine (0.15%) administration on the development of subconjunctival hemorrhage after intravitreal injection.
Kim CS; Nam KY; Kim JY
Retina; 2011 Feb; 31(2):389-92. PubMed ID: 20890238
[TBL] [Abstract][Full Text] [Related]
3. Effects of topical clonidine versus brimonidine on choroidal blood flow and intraocular pressure during squatting.
Weigert G; Resch H; Garhofer G; Fuchsjäger-Mayrl G; Schmetterer L
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4220-5. PubMed ID: 17724210
[TBL] [Abstract][Full Text] [Related]
4. [Hypotensive effect of three different formulations of brimonidine tartrate in normal eyes].
Abud TB; Scuoteguazza Filho M; Oliveira ES; Abud JF; Prata Junior JA
Arq Bras Oftalmol; 2013; 76(2):69-71. PubMed ID: 23828464
[TBL] [Abstract][Full Text] [Related]
5. Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency.
Loma P; Guzman-Aranguez A; Perez de Lara MJ; Pintor J
Exp Eye Res; 2015 May; 134():141-7. PubMed ID: 25701803
[TBL] [Abstract][Full Text] [Related]
6. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification.
Cetinkaya A; Akman A; Akova YA
J Cataract Refract Surg; 2004 Aug; 30(8):1736-41. PubMed ID: 15313300
[TBL] [Abstract][Full Text] [Related]
7. Effect of brimonidine on corneal thickness.
Grueb M; Mielke J; Rohrbach JM; Schlote T
J Ocul Pharmacol Ther; 2011 Oct; 27(5):503-9. PubMed ID: 21797667
[TBL] [Abstract][Full Text] [Related]
8. Effect of antiglaucoma agents on postoperative intraocular pressure after cataract surgery with Viscoat.
Borazan M; Karalezli A; Akman A; Akova YA
J Cataract Refract Surg; 2007 Nov; 33(11):1941-5. PubMed ID: 17964402
[TBL] [Abstract][Full Text] [Related]
9. [Effect of brimonidine on central corneal thickness].
Grüb M; Mielke J; Schlote T; Rohrbach M
Klin Monbl Augenheilkd; 2012 Mar; 229(3):236-40. PubMed ID: 22161473
[TBL] [Abstract][Full Text] [Related]
10. Effect of brimonidine tartrate 0.15% on scotopic pupil: controlled trial.
Gerente VM; Biondi AC; Barbosa CP; Lottenberg CL; Paranhos A
J Ocul Pharmacol Ther; 2007 Oct; 23(5):476-80. PubMed ID: 17900228
[TBL] [Abstract][Full Text] [Related]
11. Short-term effect of topical dorzolamide hydrochloride on intrastromal corneal pressure in rabbit corneas in vivo.
Teus MA; Bolívar G; Alió JL; Lipshitz I
Cornea; 2009 Feb; 28(2):206-10. PubMed ID: 19158566
[TBL] [Abstract][Full Text] [Related]
12. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
[TBL] [Abstract][Full Text] [Related]
13. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
[TBL] [Abstract][Full Text] [Related]
14. Use of topical brimonidine to prevent intraocular pressure elevations following Nd:YAG-laser posterior capsulotomy.
Gartaganis SP; Mela EK; Katsimpris JM; Petropoulos JK; Karamanos NK; Koliopoulos JX
Ophthalmic Surg Lasers; 1999; 30(8):647-52. PubMed ID: 10507567
[TBL] [Abstract][Full Text] [Related]
15. Pupillographic, tonographic and refractive parameter changes after topical instillation of Brimonidine tartrate 0.2% in healthy subjects.
Brogliatti B; Bogetto C; Prandi B; Boles Carenini B
Acta Ophthalmol Scand Suppl; 1998; (227):34-5. PubMed ID: 9972337
[No Abstract] [Full Text] [Related]
16. Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate.
Becker HI; Walton RC; Diamant JI; Zegans ME
Arch Ophthalmol; 2004 Jul; 122(7):1063-6. PubMed ID: 15249377
[No Abstract] [Full Text] [Related]
17. Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure.
Liu JH; Medeiros FA; Slight JR; Weinreb RN
Ophthalmology; 2010 Nov; 117(11):2075-9. PubMed ID: 20663566
[TBL] [Abstract][Full Text] [Related]
18. Effect of latanoprost 0.005% and brimonidine 0.2% on intraocular pressure after phacoemulsification and intraocular lens implantation surgery.
Erdogan H; Toker MI; Arici MK; Topalkara A
Jpn J Ophthalmol; 2004; 48(6):600-1. PubMed ID: 15592790
[No Abstract] [Full Text] [Related]
19. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
Chen TC
J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
[TBL] [Abstract][Full Text] [Related]
20. Effect of brimonidine 0.5% on intraocular pressure spikes following 360% argon laser trabeculoplasty. The Brimonidine-ALT Study Group.
Ophthalmic Surg Lasers; 1995; 26(5):404-9. PubMed ID: 8963853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
